Joseph P. Hagan - Jan 12, 2024 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Role: Chief Executive Officer, Director
Signature: Christopher Aker, attorney in fact
Stock symbol: RGLS
Transactions as of: Jan 12, 2024
Transactions value $: $0
Form type: 4
Date filed: 1/17/2024, 05:16 PM
Previous filing: Aug 14, 2023
Next filing: Jan 18, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RGLS	Common Stock	Award	$0	+30K	+71.96%	$0.00	71.7K	Jan 12, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RGLS	Stock Option (Right to Buy)	Award	$0	+249K		$0.00	249K	Jan 12, 2024	Common Stock	249K	$1.30	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 11, 2023, the reporting person was granted Restricted Stock Units (RSUs). The RSUs only vested upon achievement of a performance-based milestone. The performance criteria were met resulting in immediate vesting of 50% of the shares subject to the grant. The remaining 50% vest on the one year anniversary of the vesting commencement date, subject to the reporting person's Continuous Service to Regulus.
F2	The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.

Content

On January 11, 2023, the reporting person was granted Restricted Stock Units (RSUs). The RSUs only vested upon achievement of a performance-based milestone. The performance criteria were met resulting in immediate vesting of 50% of the shares subject to the grant. The remaining 50% vest on the one year anniversary of the vesting commencement date, subject to the reporting person's Continuous Service to Regulus.

The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.